ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

Move to Boycott Cancer Congress Gains Some Support

January 20, 1978

ONS Congress Plans, Certification Exams Set For Pittsburgh

October 30, 1987